X |
Filing Date |
Trade Date |
Ticker |
Company Name | Industry | Ins |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3 | 2024-10-17 | AVK | Advent Convertible & Income Fund | Closed-End Funds | 3 | P - Purchase | $11.28 | +9,756 | 39,197 | +33% | +$110,048 | |||||
| 4 M | 2024-09-10 | RRGB | Red Robin Gourmet Burgers Inc | Eating Places | 3 | P - Purchase | $5.63 | +163,283 | 2,400,947 | +7% | +$919,055 | |||||
| 4 D | 2024-10-16 | ZIVO | Zivo Bioscience, Inc. | Biological Products, (No Diagnostic Substances) | 4 | P - Purchase | $9.68 | +52,802 | 1,297,751 | +4% | +$511,298 | |||||
| 3 | 2024-10-16 | FROPX | Flat Rock Opportunity Fund | Closed-End Funds | 2 | P - Purchase | $19.00 | +13,160 | 34,715 | +61% | +$250,000 | |||||
| 2 | 2024-10-11 | NEOG | Neogen Corp | In Vitro & In Vivo Diagnostic Substances | 2 | P - Purchase | $14.32 | +17,500 | 239,869 | +8% | +$250,671 | |||||
| 5 | 2024-10-10 | DKL | Delek Logistics Partners, LP | Pipe Lines (No Natural Gas) | 4 | P - Purchase | $38.99 | +12,806 | 92,196 | +16% | +$499,341 | |||||
| 7 | 2024-10-03 | CBNA | Chain Bridge Bancorp Inc | National Commercial Banks | 7 | P - Purchase | $22.00 | +15,448 | 15,448 | % | +$339,856 | |||||
| 7 D | 2024-10-02 | AHH | Armada Hoffler Properties, Inc. | Real Estate | 7 | P - Purchase | $10.51 | +307,355 | 1,160,841 | +36% | +$3,228,783 | |||||
| 8 M | 2024-10-01 | LUV | Southwest Airlines Co | Air Transportation, Scheduled | 2 | P - Purchase | $29.64 | +3,633,921 | 4,600,141 | +376% | +$107,700,111 | |||||
| 3 D | 2024-09-30 | CLNN | Clene Inc. | Pharmaceutical Preparations | 3 | P - Purchase | $4.75 | +122,819 | 522,975 | +31% | +$583,390 |
X |
Filing Date |
Trade Date |
Ticker |
Company Name | Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2024-10-18 | DYNR | Dynaresource Inc | Rose Matthew K | Dir, 10% | P - Purchase | $1.04 | +1,495,000 | 4,766,894 | +46% | +$1,554,800 | ||||||
| M | 2024-10-18 | FBK | Fb Financial Corp | Ayers James W. | 10% | P - Purchase | $48.58 | +5,500 | 10,896,341 | 0% | +$267,170 | |||||
| AD | 2024-10-15 | CAMP | Camp4 Therapeutics Corp | Polaris Management Co. Vii, L.L.C. | 10% | P - Purchase | $11.00 | +909,090 | 909,090 | New | +$9,999,990 | |||||
| M | 2024-10-18 | TTSH | Tile Shop Holdings, Inc. | Fund 1 Investments, LLC | 10% | P - Purchase | $6.73 | +46,500 | 9,036,876 | +1% | +$312,816 | |||||
| M | 2024-10-18 | RMCF | Rocky Mountain Chocolate Factory, Inc. | Global Value Investment Corp. | 10% | P - Purchase | $2.18 | +31,109 | 1,316,882 | +2% | +$67,901 | |||||
| M | 2024-10-18 | RMCF | Rocky Mountain Chocolate Factory, Inc. | Geygan Jeffrey Richart | Interim CEO, 10% | P - Purchase | $2.18 | +31,109 | 1,316,882 | +2% | +$67,901 | |||||
2024-10-18 | JANX | Janux Therapeutics, Inc. | Ra Capital Management, L.P. | Dir, 10% | P - Purchase | $44.75 | +1,200,000 | 10,365,652 | +13% | +$53,700,000 | ||||||
| D | 2024-10-18 | DYNR | Dynaresource Inc | Nichol Gareth | 10% | P - Purchase | $1.04 | +2,778,846 | 5,425,768 | +105% | +$2,890,000 | |||||
2024-10-21 | BIGZ | Blackrock Innovation & Growth Term Trust | Saba Capital Management, L.P. | 10% | P - Purchase | $7.59 | +64,641 | 56,514,257 | 0% | +$490,625 | ||||||
2024-10-18 | HEI | Heico Corp | Schriesheim Alan | Dir | P - Purchase | $262.94 | +724 | 203,115 | 0% | +$190,368 |
X |
Filing Date |
Trade Date |
Ticker |
Company Name | Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2024-10-18 | DYNR | Dynaresource Inc | Rose Matthew K | Dir, 10% | P - Purchase | $1.04 | +1,495,000 | 4,766,894 | +46% | +$1,554,800 | ||||||
| M | 2024-10-18 | RMCF | Rocky Mountain Chocolate Factory, Inc. | Global Value Investment Corp. | 10% | P - Purchase | $2.18 | +31,109 | 1,316,882 | +2% | +$67,901 | |||||
| M | 2024-10-18 | RMCF | Rocky Mountain Chocolate Factory, Inc. | Geygan Jeffrey Richart | Interim CEO, 10% | P - Purchase | $2.18 | +31,109 | 1,316,882 | +2% | +$67,901 | |||||
| D | 2024-10-18 | DYNR | Dynaresource Inc | Nichol Gareth | 10% | P - Purchase | $1.04 | +2,778,846 | 5,425,768 | +105% | +$2,890,000 | |||||
| M | 2024-10-09 | LGMK | Logicmark, Inc. | Winvest Investment Fund Management Corp. | 10% | P - Purchase | $0.09 | +3,464,987 | 4,074,587 | +568% | +$306,880 | |||||
2024-10-15 | RFIL | R F Industries Ltd | Holdsworth Mark Keith | Dir | P - Purchase | $4.00 | +7,009 | 862,259 | +1% | +$28,029 | ||||||
2024-10-16 | SCLX | Scilex Holding Co | Shah Jaisim | See Remarks | P - Purchase | $0.99 | +30,000 | 233,215 | +15% | +$29,751 | ||||||
2024-10-16 | APRE | Aprea Therapeutics, Inc. | Duey Marc | Dir | P - Purchase | $4.39 | +30,000 | 240,715 | +14% | +$131,700 | ||||||
2024-10-15 | EONR | Eon Resources Inc. | Williams Mark | VP of Finance, Admin | P - Purchase | $1.00 | +50,000 | 95,000 | +111% | +$50,000 | ||||||
2024-10-15 | EONR | Eon Resources Inc. | Caravaggio Dante | CEO | P - Purchase | $1.09 | +110,000 | 649,440 | +20% | +$120,100 |
X |
Filing Date |
Trade Date |
Ticker |
Company Name | Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2024-10-21 | NTRA | Natera, Inc. | Chapman Steven Leonard | CEO, Pres | S - Sale+OE | $120.52 | -2,602 | 193,722 | -1% | -$313,597 | |||||
| DM | 2024-10-21 | NTRA | Natera, Inc. | Brophy Michael Burkes | CFO | S - Sale+OE | $120.46 | -1,062 | 73,560 | -1% | -$127,932 | |||||
| D | 2024-10-21 | ROIV | Roivant Sciences Ltd. | Venker Eric | Pres, COO | S - Sale+OE | $11.65 | -100,000 | 617,470 | -14% | -$1,165,000 | |||||
| M | 2024-10-18 | VRNA | Verona Pharma Plc | Zaccardelli David | Pres, CEO | S - Sale | $4.38 | -514,152 | 14,736,552 | -3% | -$2,253,237 | |||||
| M | 2024-10-18 | VRNA | Verona Pharma Plc | Hahn Mark W | CFO | S - Sale | $4.38 | -525,768 | 13,813,920 | -4% | -$2,303,773 | |||||
| D | 2024-10-22 | RXST | Rxsight, Inc. | Goldshleger Ilya | See remarks | S - Sale+OE | $49.68 | -3,100 | 43,618 | -7% | -$154,001 | |||||
2024-10-18 | ACR | Acres Commercial Realty Corp. | Eagle Point Credit Management LLC | 10% | S - Sale | $23.38 | -10,601 | 2,611,776 | 0% | -$247,865 | ||||||
| D | 2024-10-22 | CRM | Salesforce, Inc. | Millham Brian | Pres, COO | S - Sale+OE | $289.75 | -6,161 | 0 | -100% | -$1,785,150 | |||||
| D | 2024-10-22 | CRM | Salesforce, Inc. | Harris Parker | Co-Founder, CTO, Slack | S - Sale+OE | $288.82 | -4,200 | 1,926,992 | 0% | -$1,213,055 | |||||
| D | 2024-10-18 | CXDO | Crexendo, Inc. | Gaylor Douglas Walter | COO | S - Sale+OE | $6.00 | -30,000 | 219,083 | -12% | -$180,000 |
X |
Filing Date |
Trade Date |
Ticker |
Company Name | Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2024-10-21 | NTRA | Natera, Inc. | Rabinowitz Daniel | SEC., GC | S - Sale+OE | $120.46 | -816 | 207,084 | 0% | -$98,298 | |||||
| DM | 2024-10-21 | NTRA | Natera, Inc. | Chapman Steven Leonard | CEO, Pres | S - Sale+OE | $120.52 | -2,602 | 193,722 | -1% | -$313,597 | |||||
| DM | 2024-10-21 | NTRA | Natera, Inc. | Brophy Michael Burkes | CFO | S - Sale+OE | $120.46 | -1,062 | 73,560 | -1% | -$127,932 | |||||
| D | 2024-10-20 | ROIV | Roivant Sciences Ltd. | Venker Eric | Pres, COO | F - Tax | $11.92 | -10,945 | 617,470 | -2% | -$130,464 | |||||
| D | 2024-10-21 | ROIV | Roivant Sciences Ltd. | Venker Eric | Pres, COO | M - OptEx | $3.85 | +100,000 | 617,470 | +19% | +$385,000 | |||||
| D | 2024-10-21 | ROIV | Roivant Sciences Ltd. | Venker Eric | Pres, COO | S - Sale+OE | $11.65 | -100,000 | 617,470 | -14% | -$1,165,000 | |||||
2024-10-20 | ROIV | Roivant Sciences Ltd. | Kumar Rakhi | Chief Accounting Officer | F - Tax | $11.92 | -956 | 208,366 | 0% | -$11,396 | ||||||
2024-10-20 | ROIV | Roivant Sciences Ltd. | Gline Matthew | CEO | F - Tax | $11.92 | -10,945 | 17,361,059 | 0% | -$130,464 | ||||||
| M | 2024-10-18 | VRNA | Verona Pharma Plc | Zaccardelli David | Pres, CEO | S - Sale | $4.38 | -514,152 | 14,736,552 | -3% | -$2,253,237 | |||||
| M | 2024-10-18 | VRNA | Verona Pharma Plc | Hahn Mark W | CFO | S - Sale | $4.38 | -525,768 | 13,813,920 | -4% | -$2,303,773 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |